Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Novel Compound for Alcoholism Treatment: A Translational Strategy

NCT02039349 is registered in ClinicalTrials.gov with National Institute on Alcohol Abuse and Alcoholism (NIAAA) as lead sponsor.

NCT NCT02039349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02039349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Novel Compound for Alcoholism Treatment: A Translational Strategy
Lead sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Phase
Phase 1
Overall status
Completed
Start date
January 3, 2014
Completion date
December 24, 2017
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence, alcohol drinking, alcohol drinking related problems, alcohol-related disorders, alcoholism